Anton Fliri

684 total citations
18 papers, 514 citations indexed

About

Anton Fliri is a scholar working on Molecular Biology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Anton Fliri has authored 18 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Computational Theory and Mathematics and 6 papers in Organic Chemistry. Recurrent topics in Anton Fliri's work include Computational Drug Discovery Methods (10 papers), Synthesis and biological activity (4 papers) and Bioinformatics and Genomic Networks (4 papers). Anton Fliri is often cited by papers focused on Computational Drug Discovery Methods (10 papers), Synthesis and biological activity (4 papers) and Bioinformatics and Genomic Networks (4 papers). Anton Fliri collaborates with scholars based in United States, Austria and Netherlands. Anton Fliri's co-authors include William Loging, Robert A. Volkmann, Peter F. Thadeio, Shama Kajiji, Rodney C. Schnur, Albert Eschenmoser, Gerard Costello, Vincent A. Pollack, Heinz E. Moser and J. Schreiber and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and Trends in Pharmacological Sciences.

In The Last Decade

Anton Fliri

15 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anton Fliri United States 10 351 329 98 88 68 18 514
Mike Hann United Kingdom 4 374 1.1× 393 1.2× 61 0.6× 146 1.7× 81 1.2× 6 628
Nathalie Lagarde France 15 310 0.9× 292 0.9× 63 0.6× 124 1.4× 90 1.3× 34 593
Peter Monecke Germany 12 433 1.2× 345 1.0× 26 0.3× 104 1.2× 75 1.1× 19 726
Peter Ripphausen Germany 7 332 0.9× 336 1.0× 30 0.3× 125 1.4× 74 1.1× 8 562
Elisabet Gregori‐Puigjané Spain 13 524 1.5× 483 1.5× 96 1.0× 103 1.2× 154 2.3× 14 785
Tuomo Kalliokoski Finland 14 509 1.5× 470 1.4× 48 0.5× 208 2.4× 109 1.6× 23 803
Constantine Kreatsoulas United States 7 300 0.9× 269 0.8× 31 0.3× 72 0.8× 77 1.1× 12 449
Sanna Niinivehmas Finland 13 286 0.8× 205 0.6× 53 0.5× 123 1.4× 74 1.1× 22 517
Violeta I. Pérez‐Nueno France 15 384 1.1× 400 1.2× 50 0.5× 45 0.5× 107 1.6× 25 586
Bryan J. Witherbee United States 8 326 0.9× 226 0.7× 38 0.4× 159 1.8× 47 0.7× 9 566

Countries citing papers authored by Anton Fliri

Since Specialization
Citations

This map shows the geographic impact of Anton Fliri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Fliri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Fliri more than expected).

Fields of papers citing papers by Anton Fliri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anton Fliri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Fliri. The network helps show where Anton Fliri may publish in the future.

Co-authorship network of co-authors of Anton Fliri

This figure shows the co-authorship network connecting the top 25 collaborators of Anton Fliri. A scholar is included among the top collaborators of Anton Fliri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anton Fliri. Anton Fliri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Fliri, Anton & Shama Kajiji. (2024). Effects of vitamin D signaling in cardiovascular disease: centrality of macrophage polarization. Frontiers in Cardiovascular Medicine. 11. 1388025–1388025.
2.
Fliri, Anton & Shama Kajiji. (2023). Vitamin D Deficiency-Associated Comorbidities: A Protein Network Dynamics Perspective. Medical Research Archives. 11(6). 1 indexed citations
3.
Fliri, Anton, William Loging, & Robert A. Volkmann. (2011). Analysis of information flows in interaction networks: implication for drug discovery and pharmacological research.. PubMed. 11(57). 133–43. 3 indexed citations
4.
Fliri, Anton, William Loging, & Robert A. Volkmann. (2010). Cause-effect relationships in medicine: a protein network perspective. Trends in Pharmacological Sciences. 31(11). 547–555. 28 indexed citations
5.
Fliri, Anton, William Loging, & Robert A. Volkmann. (2009). Drug Effects Viewed from a Signal Transduction Network Perspective. Journal of Medicinal Chemistry. 52(24). 8038–8046. 26 indexed citations
6.
Mente, Scot, et al.. (2008). Quantitative structure–activity relationship of phenoxyphenyl-methanamine compounds with 5HT2A, SERT, and hERG activities. Bioorganic & Medicinal Chemistry Letters. 18(23). 6088–6092. 7 indexed citations
7.
Fliri, Anton, William Loging, & Robert A. Volkmann. (2007). Analysis of System Structure–Function Relationships. ChemMedChem. 2(12). 1774–1782. 21 indexed citations
8.
Fliri, Anton, William Loging, Peter F. Thadeio, & Robert A. Volkmann. (2005). Analysis of drug-induced effect patterns to link structure and side effects of medicines. Nature Chemical Biology. 1(7). 389–397. 123 indexed citations
9.
Volkmann, Robert A. & Anton Fliri. (2005). Response to Froloff: Probing system structure–effect relationships. Trends in biotechnology. 23(10). 490–491. 1 indexed citations
10.
Fliri, Anton, William Loging, Peter F. Thadeio, & Robert A. Volkmann. (2005). Biospectra Analysis:  Model Proteome Characterizations for Linking Molecular Structure and Biological Response. Journal of Medicinal Chemistry. 48(22). 6918–6925. 63 indexed citations
11.
Fliri, Anton, William Loging, Peter F. Thadeio, & Robert A. Volkmann. (2004). Biological spectra analysis: Linking biological activity profiles to molecular structure. Proceedings of the National Academy of Sciences. 102(2). 261–266. 140 indexed citations
12.
Chappie, Thomas A., A. DUNAISKIS, Anton Fliri, et al.. (1998). Synthesis, sar and pharmacology of CP-293,019: A potent, selective dopamine D4 receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 8(7). 725–730. 28 indexed citations
13.
Faraci, W. Stephen, Stevin H. Zorn, Mark A. Sanner, & Anton Fliri. (1998). The discovery of potent and selective dopamine D4 receptor antagonists. Current Opinion in Chemical Biology. 2(4). 535–540. 9 indexed citations
14.
15.
Schnur, Rodney C., Anton Fliri, Shama Kajiji, & Vincent A. Pollack. (1991). N-(5-fluorobenzothiazol-2-yl)-2-guanidinothiazole-4-carboxamide. A novel, systemically active antitumor agent effective against 3LL Lewis Lung carcinoma. Journal of Medicinal Chemistry. 34(3). 914–918. 19 indexed citations
17.
Moser, Heinz E., et al.. (1986). Poly(dipeptamidinium)‐Salze: Definition und Methoden zur präparativen Herstellung. Helvetica Chimica Acta. 69(5). 1224–1262. 27 indexed citations
18.
Fliri, Anton, et al.. (1980). Eine stereospezifische Totalsynthese von (±)‐Biotin. Chemische Berichte. 113(2). 607–613. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026